There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals...
Keep Reading →
March 14 - Hedge Funds, News - Comments
Bioscrip Inc. (NASDAQ:BIOS): Philip Hempleman’s Ardsley Partners filed an amended 13D. You can check out Ardsley Partners’ latest holdings...
Keep Reading →
January 26 - Hedge Funds - Comments
Bioscrip Inc. (NASDAQ:BIOS): Jeffrey Bersh And Michael Wartell’s Venor Capital Management filed an amended 13D. You can check out Venor Capital...
Keep Reading →
November 8 - Hedge Funds - Comments
Bioscrip Inc. (NASDAQ:BIOS): Christopher Shackelton And Adam Gray’s Coliseum Capital filed an amended 13D. You can check out Coliseum Capital’...
Keep Reading →
September 11 - Hedge Funds - Comments
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that...
Keep Reading →
September 1 - Lists, News - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
August 21 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 17 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington...
Keep Reading →
August 14 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 17 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington...
Keep Reading →
July 14 - Hedge Funds - Comments
In my “Technically Speaking” analyses, I’ll take a look at up to three stocks that have entered into either an overbought or oversold...
Keep Reading →
November 9 - News, Stock Analysis - Comments
Hudson Bay Capital Unloads Over 3 Million Shares of HC2 Holdings According to a freshly-amended 13D filing with the SEC, Sander Gerber‘s Hudson Bay...
Keep Reading →
October 19 - Hedge Funds, News - Comments
Billionaire Mario Gabelli‘s GAMCO Investors recently filed an amended Form 13D with the US Securities and Exchange Commission, in which it reported...
Keep Reading →
October 19 - Hedge Funds, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Corporate insiders, namely executives and Board members, are usually privy to a great deal of up-to-date information about current developments or future...
Keep Reading →
June 21 - Insider Trading, News - Comments
With the markets on edge over a potential Brexit and the FOMC meeting scheduled for this week, the coming days may be more volatile than expected. Among...
Keep Reading →
June 13 - Market Movers, News - Comments
Brian Newman and David Heller’s Cloud Gate Capital, one of the newest additions to our database of more than 700 top hedge funds, was a big winner on...
Keep Reading →
April 1 - Hedge Funds, News - Comments
Christopher Shackelton and Adam Gray’s Coliseum Capital initiated a new position in BioScrip Inc (NASDAQ:BIOS), according to a recent 13D filing...
Keep Reading →
March 20 - Hedge Funds, News - Comments
Ken Griffin’s Citadel Investment Group disclosed a large purchase in Rosetta Resources (NASDAQ:ROSE) this week. According to the 13G Form filed with...
Keep Reading →
February 10 - Hedge Funds, News - Comments
GAMCO Investors and other funds managed by Mario Gabelli continue to aggressively add to their holdings in BioScrip Inc (NASDAQ:BIOS), having increased...
Keep Reading →
January 28 - Hedge Funds, News - Comments
Mario Gabelli’s GAMCO Investors and James E. Flynn’s Deerfield Management seem bullish on BioScrip Inc (NASDAQ:BIOS) and Proteon Therapeutics Inc (...
Keep Reading →
October 27 - Hedge Funds, News - Comments
A few days ago, Phil Frohlich’s Prescott Group Capital Management filed its 13F for the second quarter of 2014. In this document, the hedge fund disclosed...
Keep Reading →
July 23 - Hedge Funds, News - Comments
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower...
Keep Reading →
May 27 - Hedge Funds, News - Comments
In another round of filing with the Securities and Exchange Commission, Mario Gabelli has revealed his latest moves. Together with GAMCO Investors and...
Keep Reading →
April 2 - Hedge Funds, News - Comments
Alan Fournier‘s hedge fund, Pennant Capital Management, reported in a new filing boosting its exposure at BioScrip Inc (NASDAQ:BIOS) to some 5.74...
Keep Reading →
November 8 - Hedge Funds, News - Comments
Is Rite Aid Corporation (NYSE:RAD) a good investment? To the average investor, there are many methods market participants can use to watch their holdings...
Keep Reading →
August 29 - News - Comments
At the moment, there are tons of methods market participants can use to track publicly traded companies. Two of the most innovative are hedge fund and...
Keep Reading →
August 26 - News - Comments
BioScrip Inc. (NASDAQ:BIOS) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. BIOS investors should pay attention to an...
Keep Reading →
June 10 - News - Comments
PharMerica Corporation (NYSE:PMC) shareholders have witnessed an increase in hedge fund interest in recent months. In the financial world, there are plenty...
Keep Reading →
June 7 - News - Comments
Walgreen Company (NYSE:WAG) was in 52 hedge funds’ portfolio at the end of the first quarter of 2013. WAG shareholders have witnessed a decrease...
Keep Reading →
May 24 - News - Comments
Is CVS Caremark Corporation (NYSE:CVS) an outstanding investment right now? The smart money is getting less optimistic. The number of bullish hedge fund...
Keep Reading →
May 23 - News - Comments
BioScrip Inc. (NASDAQ:BIOS) was in 11 hedge funds’ portfolio at the end of December. BIOS investors should be aware of a decrease in hedge fund...
Keep Reading →
April 12 - News - Comments
Wilbur Ross, the manager of WL Ross & Co., is one of the financial world’s most renowned experts on the subjects of bankruptcy and restructuring...
Keep Reading →
November 13 - Hedge Funds - Comments
CVS Caremark Corporation (NYSE:CVS) recently reported its preliminary financial results based on which we provide a unique peer-based analysis of the...
Keep Reading →
November 7 - Stock Analysis - Comments
